Skip to main content

Antiemetic Strategies for High-Dose Chemoradiotherapy-Induced Nausea and Vomiting

  • Conference paper
Perugia Consensus Conference on Antiemetic Therapy

Abstract

The treatment of nausea and vomiting in patients receiving high doses of irradiation and/or chemotherapeutic agents as preparation for hematopoietic stem cell transplantation is discussed.

Such patients have very high rates of both early and delayed emesis. Based on the available evidence, it is recommended that 5-HT3 receptor antagonists be used to combat emesis in this setting. Continued research is also required to define the optimal antiemetic strategy for these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Agura ED, Cleveland Brown M, Schaffer R, Donaldson G, Shen DD (1995) Anti-emetic efficacy and pharmacokinetics of intravenous ondansetron infusion during chemotherapy conditioning for bone marrow transplant. Bone Marrow Transplant 16: 213–222

    PubMed  CAS  Google Scholar 

  2. Barbounis V, Koumakis G, Vassilomanolakis M, Hatzichristou H, Tsousis S, Efremidis AP (1995) A phase II study of ondansetron as antiemetic prophylaxis in patients receiving high-dose polychemotherapy and stem cell transplantation 3: 301–306

    CAS  Google Scholar 

  3. Bosi A, Guidi S, Messori A et al (1993) Ondansetron versus chlorpromazine for preventing emesis in born marrow transplant recipients: a double-blind randomized study. J Chemother 5: 191–196

    PubMed  CAS  Google Scholar 

  4. Di Piro CV, Sanal SM, Harkness KT et al (1996) The anti-emetic efficacy of intravenous ondansetron at conventional versus low dose in women with early stage breast cancer. Proc Am Soc Clin Oncol 15: 540

    Google Scholar 

  5. Feuvret L, Jammet P, Campana F, Cosset JM, Fourquet A (1994) Interet du granisetron dans la prevention des troubles digestifs lors des irradiations corporelles totales. Bull Cancer/Radiother 81: 41–44

    CAS  Google Scholar 

  6. Grant Prentice H, Cunningham S, Gandhi L, Cunningham J, Collis C, Harmon MD (1995) Granisetron in the prevention of irradiation-induced emesis. Bone Marrow Transplant 15: 445–448

    Google Scholar 

  7. Hewitt M, Cornish J, Pamphilon D, Oakhill A (1991) Effective emetic control during conditioning of children for bone marrow transplantation using ondansetron, a 5-HT3 receptor antagonist. Bone Marrow Transplant 7: 431–433

    PubMed  CAS  Google Scholar 

  8. Hunter AE, Prentice HG, Pothecary K et al (1991) Granisetron, a selective 5-HT3 receptor antagonist, for the prevention of radiation induced emesis during total body irradiation. Bone Marrow Transplant 7: 439–441

    PubMed  CAS  Google Scholar 

  9. Jurgens H, McQuade B (1992) Ondansetron as prophylaxis for chemotherapy and radiotherapy induced emesis in children. Oncology 49: 279–285

    Article  PubMed  CAS  Google Scholar 

  10. Koleck P, Wachowiak J, Beshari SE (1993) Ondansetron as an effective drug in prophylaxis of chemotherapy-induced emesis in children. Acta Haematol Pol 24: 115–122

    Google Scholar 

  11. Okamoto S, Takahashi S, Tanosaki R et al (1996) Granisetran in the prevention of vomiting induced by conditioning for stem cell transplantation: a prospective randomized study. Bone Marrow Transplant 17: 679–683

    PubMed  CAS  Google Scholar 

  12. Or R, Drakos P, Nagler A, Naparstek E, Kapelushnik J, Cass Y (1994) The anti-emetic efficacy and tolerability of tropisetron in patients with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantation. Support Care Cancer 2: 245–248

    Article  PubMed  CAS  Google Scholar 

  13. Schwella N, Konig V, Schwerdtfeger R et al (1994) Ondansetron for efficient emesis control during total body irradiation. Bone Marrow Transplant 13: 169–171

    PubMed  CAS  Google Scholar 

  14. Spitzer TR, Deeg HJ, Torrisi J et al (1990) Total body irradiation induced emesis is universal after small dose fractions (120 cGy) and is not cumulative dose related. Proc ASCO 9: 14

    Google Scholar 

  15. Spitzer TR, Bryson JC, Cirenza E et al (1994) Randomized double-blind, placebo-controlled evaluation of oral ondansetron in the prevention of nausea and vomiting associated with fractionated total-body irradiation. J Clin Oncol 12: 2432–2435

    PubMed  CAS  Google Scholar 

  16. Tiley C, Powles R, Catalano J et al (1992) Results of a double blind placebo controlled study of ondansetron as an antiemetic during total body irradiation in patients undergoing bone marrow transplantation. Leuk Lymph 7: 317–321

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Spitzer, T.R., Grunberg, S.M., Dicato, M.A. (1998). Antiemetic Strategies for High-Dose Chemoradiotherapy-Induced Nausea and Vomiting. In: Gralla, R.J., Tonato, M., Roila, F. (eds) Perugia Consensus Conference on Antiemetic Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72137-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72137-3_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-72139-7

  • Online ISBN: 978-3-642-72137-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics